ACRO Biomedical Co Ltd 주요 수익원은 Rental이며, 최신 수익 발표에서 수익은 287,161,000입니다. 지역별로는 United States이 ACRO Biomedical Co Ltd의 주요 시장이며, 수익은 291,761,000입니다.
PetroSun Inc은 수익성이 있나요?
no, 최신 재무제표에 따르면 ACRO Biomedical Co Ltd의 순손실은 $0입니다.
PetroSun Inc에 부채가 있나요?
no, ACRO Biomedical Co Ltd의 부채는 0입니다.
PetroSun Inc의 발행 주식은 몇 주인가요?
ACRO Biomedical Co Ltd의 총 발행 주식은 0주입니다.
주요 통계
이전 종가
$0.012
시가
$0.015
일일 범위
$0.015 - $0.0155
52주 범위
$0.0027 - $0.0231
거래량
3.0K
평균 거래량
89.7K
배당수익률
--
EPS(TTM)
--
시가총액
$9.8M
PSUD란 무엇인가요?
PetroSun, Inc. is a diversified energy company, which engages in the exploration, production, processing, and distribution of oil, natural gas, helium and lithium. The company is headquartered in Mesa, Arizona. The company went IPO on 2006-04-28. The company owns mineral leases that are variously prospective for helium, oil and natural gas in the Holbrook Basin of Arizona, the Four Corners region of New Mexico, and in the Golden Eagle Gas Field of Utah. The Holbrook Basin is located in the eastern and central area of Arizona on the Colorado Plateau. The firm holds a range of investments relating to wastewater purification, intensive agriculture growth, solar thermal membrane filtration, and solar-rechargeable battery- and bicycle-powered micromobility vehicles. The company also holds other media and publishing assets. The firm's Golden Eagle Project is situated in the northern part of the productive Paradox Basin, in the south-eastern part of Utah.